{"id":34654,"date":"2026-09-18T14:38:31","date_gmt":"2026-09-18T11:38:31","guid":{"rendered":"https:\/\/akdenizolay.com.tr\/index.php\/2026\/09\/18\/alzheimerda-bilimsel-gelismeler-hizlaniyor-hastalarin-beklentisi-buyuyor\/"},"modified":"2026-09-18T14:38:31","modified_gmt":"2026-09-18T11:38:31","slug":"alzheimerda-bilimsel-gelismeler-hizlaniyor-hastalarin-beklentisi-buyuyor","status":"publish","type":"post","link":"https:\/\/akdenizolay.com.tr\/index.php\/2026\/09\/18\/alzheimerda-bilimsel-gelismeler-hizlaniyor-hastalarin-beklentisi-buyuyor\/","title":{"rendered":"Alzheimer\u2019da bilimsel geli\u015fmeler h\u0131zlan\u0131yor, hastalar\u0131n beklentisi b\u00fcy\u00fcyor"},"content":{"rendered":"

21 Eyl\u00fcl D\u00fcnya Alzheimer G\u00fcn\u00fc vesilesiyle d\u00fczenlenen bas\u0131n toplant\u0131s\u0131nda; Alzheimer hastal\u0131\u011f\u0131nda tan\u0131 ve tedavi alan\u0131ndaki g\u00fcncel bilimsel geli\u015fmeler, yeni tedavilere eri\u015fim, hastal\u0131\u011f\u0131n davran\u0131\u015fsal belirtileri ve bak\u0131m verenlerin ya\u015fad\u0131\u011f\u0131 zorluklar ele al\u0131nd\u0131.<\/strong><\/p>\n

T\u00fcrkiye Alzheimer Derne\u011fi Y\u00f6netim Kurulu Ba\u015fkan\u0131 Dilek \u015eahin\u00f6z, T\u00fcrkiye Alzheimer Derne\u011fi T\u0131bbi Kurul Ba\u015fkan\u0131 Prof. Dr. Ba\u015far Bilgi\u00e7, T\u00fcrkiye Alzheimer Derne\u011fi Y\u00f6netim Kurulu \u00dcyesi ve hasta yak\u0131n\u0131 Hatice Serta\u00e7 S\u00fcsl\u00fc ile Abdi \u0130brahim Otsuka Genel M\u00fcd\u00fcr\u00fc Zeynep Alptekin Basa\u2019n\u0131n kat\u0131ld\u0131\u011f\u0131 toplant\u0131da g\u00fcncel geli\u015fmeler ile y\u00fcr\u00fct\u00fclen kampanyalara dikkat \u00e7ekildi. \u00a0<\/strong><\/p>\n

D\u00fcnyada Alzheimer hastal\u0131\u011f\u0131n\u0131n ilerlemesini yava\u015flatan yeni ila\u00e7lar\u0131n kullan\u0131ma girmesi, zona a\u015f\u0131s\u0131n\u0131n demans riskini d\u00fc\u015f\u00fcrd\u00fc\u011f\u00fcn\u00fc g\u00f6steren veriler, ajitasyon (h\u0131r\u00e7\u0131nl\u0131k) belirtilerine y\u00f6nelik onayl\u0131 tedaviler ve erken tan\u0131y\u0131 kolayla\u015ft\u0131ran kan testleri Alzheimer hastal\u0131\u011f\u0131n\u0131n gelece\u011fine ili\u015fkin umut verici geli\u015fmeler aras\u0131nda yer al\u0131yor. Bu g\u00fcncel geli\u015fmeler heyecan yarat\u0131rken, hastalar ve hasta yak\u0131nlar\u0131 h\u00e2l\u00e2 bir\u00e7ok zorluk ve engelle \u00e7o\u011fu kez tek ba\u015flar\u0131na m\u00fccadele etmek zorunda kal\u0131yor; T\u00fcrkiye\u2019de ise bu \u00f6nemli yeniliklere eri\u015fimin art\u0131r\u0131lmas\u0131 \u00f6nem ta\u015f\u0131yor.\u00a0<\/p>\n

Yeni Alzheimer tedavilerine eri\u015fim \u00f6nemli\u00a0<\/strong><\/p>\n

T\u00fcrkiye Alzheimer Derne\u011fi Y\u00f6netim Kurulu Ba\u015fkan\u0131 Dilek \u015eahin\u00f6z<\/strong>, Alzheimer hastal\u0131\u011f\u0131nda beyinde biriken \u201camiloid\u201d adl\u0131 maddeyi temizleyen ila\u00e7lar\u0131n hastal\u0131\u011f\u0131n ilerlemesini yava\u015flatt\u0131\u011f\u0131n\u0131 ve g\u00fcn\u00fcm\u00fczde d\u00fcnya \u00e7ap\u0131nda kullan\u0131lmaya ba\u015fland\u0131\u011f\u0131n\u0131 belirtti. Bu ila\u00e7lar\u0131n etkinli\u011fi ve g\u00fcvenli\u011finin y\u00fczlerce hastan\u0131n kat\u0131ld\u0131\u011f\u0131 kontroll\u00fc \u00e7al\u0131\u015fmalar ve d\u00f6rt y\u0131ldan uzun s\u00fcren takiplerle g\u00f6sterildi\u011fini ifade eden \u015eahin\u00f6z, uzun s\u00fcreli verilerin ilac\u0131n etkisinin uzun vadeli oldu\u011funu ve ortaya \u00e7\u0131kabilecek yan etkilerin d\u00fczenli kontrollerle y\u00f6netilebildi\u011fini g\u00f6sterdi\u011fini s\u00f6yledi. \u0130la\u00e7 uygulamas\u0131nda bazen beyin i\u00e7inde s\u0131v\u0131 toplanmas\u0131 veya k\u00fc\u00e7\u00fck kanamalar g\u00f6r\u00fclebildi\u011fini; ancak belirli hasta se\u00e7imi ve tedavi protokollerinin bu riskleri azaltabildi\u011fini aktard\u0131.<\/p>\n

Bu ila\u00e7lar\u0131n T\u00fcrkiye\u2019de h\u00e2l\u00e2 eri\u015filebilir olmad\u0131\u011f\u0131na dikkat \u00e7eken \u015eahin\u00f6z, yeni tedavilere adil ve zaman\u0131nda eri\u015fimin sa\u011flanabilmesi i\u00e7in ilgili t\u00fcm payda\u015flar\u0131n katk\u0131s\u0131n\u0131n \u00f6nem ta\u015f\u0131d\u0131\u011f\u0131n\u0131 belirtti. \u015eahin\u00f6z, bununla birlikte ilac\u0131n uzun d\u00f6nem etkilerini izleyecek sistemlerin kurulmas\u0131, geri \u00f6deme d\u00fczenlemelerinin yap\u0131lmas\u0131 ve uygulama i\u00e7in gerekli sa\u011fl\u0131k altyap\u0131s\u0131n\u0131n h\u0131zla hayata ge\u00e7irilmesi gerekti\u011fini vurgulad\u0131.<\/p>\n

Yeni kan testleri ile Alzheimer tan\u0131s\u0131 m\u00fcmk\u00fcn ama kimlere, nas\u0131l yap\u0131lmal\u0131?<\/strong><\/p>\n

T\u00fcrkiye Alzheimer Derne\u011fi T\u0131bbi Kurul Ba\u015fkan\u0131 Prof. Dr. Ba\u015far Bilgi\u00e7<\/strong>, son d\u00f6nemde T\u00fcrkiye\u2019de \u00e7e\u015fitli klinik laboratuvarlarda, kandan Alzheimer tan\u0131s\u0131 i\u00e7in bak\u0131lan \u201cpTau-217\u201d isimli testin uygulanmaya ba\u015fland\u0131\u011f\u0131n\u0131 belirterek, geli\u015fmi\u015f \u00fclkelerle ayn\u0131 d\u00f6nemde bu testlerin T\u00fcrkiye\u2019de hizmete girmesinin sevindirici bir geli\u015fme oldu\u011funu ifade etti.<\/p>\n

\u201cpTau-217\u201dnin Alzheimer hastal\u0131\u011f\u0131 ile ili\u015fkili erken beyin de\u011fi\u015fikliklerini yans\u0131tan bir biyobelirte\u00e7 oldu\u011funu ve uygun ba\u011flamda kullan\u0131ld\u0131\u011f\u0131nda tan\u0131sal de\u011ferlendirmeye \u00e7ok de\u011ferli bir katk\u0131 sa\u011flad\u0131\u011f\u0131n\u0131 belirten Bilgi\u00e7, bu yeni olana\u011fa ili\u015fkin \u00f6nemli uyar\u0131larda da bulundu. \u201cpTau-217\u201dnin bir\u00e7ok farkl\u0131 platformda \u00f6l\u00e7\u00fclebildi\u011fine dikkat \u00e7eken Bilgi\u00e7, yaln\u0131zca do\u011frulanm\u0131\u015f ve g\u00fcvenilir platformlar\u0131n tercih edilmesi gerekti\u011fini s\u00f6yledi. \u00d6l\u00e7\u00fcm\u00fcn hedef kitlesinin \u015fimdilik zihinsel \u015fik\u00e2yet bildiren ki\u015filerle ve hekim iste\u011fi dahilinde s\u0131n\u0131rl\u0131 olmas\u0131 gerekti\u011fini; hi\u00e7 \u015fik\u00e2yeti olmayan sa\u011fl\u0131kl\u0131 bireylerde ise g\u00fcn\u00fcm\u00fczde hen\u00fcz yeterli veri birikmedi\u011finden yayg\u0131n tarama arac\u0131 olarak uygulanmas\u0131n\u0131n \u00f6nerilmedi\u011fini ifade etti.<\/p>\n

\u00d6n\u00fcm\u00fczdeki d\u00f6nemde \u201cpTau-217\u201dye ek olarak hastal\u0131\u011f\u0131n ilerlemesini ve \u015fiddetlenmesini \u00f6ng\u00f6ren ba\u015fka kan testlerinin de devreye girmesinin beklendi\u011fini belirten Bilgi\u00e7, biyobelirte\u00e7lerin kullan\u0131m\u0131, g\u00fcvenilir platform se\u00e7imi ve sonu\u00e7lar\u0131n yorumlanmas\u0131 konusunda ulusal k\u0131lavuz ve kalite standartlar\u0131n\u0131n h\u0131zla olu\u015fturulmas\u0131n\u0131n \u00f6nem ta\u015f\u0131d\u0131\u011f\u0131n\u0131 vurgulad\u0131. Bilgi\u00e7 ayr\u0131ca bu testlerin klinikte yayg\u0131nla\u015fabilmesi i\u00e7in geri \u00f6deme kapsam\u0131na al\u0131nmas\u0131 ve eri\u015fimin adil \u015fekilde sa\u011flanmas\u0131 gerekti\u011fini belirterek hekimlere, laboratuvarlara ve karar vericilere bu ilk uygulama d\u00f6neminde dikkatli, hedefe y\u00f6nelik ve hasta odakl\u0131 yakla\u015f\u0131m \u00e7a\u011fr\u0131s\u0131nda bulundu.<\/p>\n

A\u015f\u0131 ile beyni korumak m\u00fcmk\u00fcn m\u00fc? Zona a\u015f\u0131s\u0131 \u00fczerine dikkat \u00e7eken bulgular<\/strong><\/p>\n

Son y\u0131llarda yap\u0131lan g\u00fc\u00e7l\u00fc \u00e7al\u0131\u015fmalar ve b\u00fcy\u00fck veri analizlerinin zona (herpes zoster) a\u015f\u0131lar\u0131n\u0131n sadece zona hastal\u0131\u011f\u0131n\u0131 \u00f6nlemekle kalmay\u0131p demans riskini yakla\u015f\u0131k y\u00fczde 20 oran\u0131nda azaltabilece\u011fini ve demans\u0131 olanlarda da hastal\u0131\u011f\u0131n ilerlemesini yava\u015flatabilece\u011fini g\u00f6sterdi\u011fini belirten Prof. Dr. Ba\u015far Bilgi\u00e7<\/strong>, Galler ve Avustralya\u2019daki \u00e7al\u0131\u015fmalarda a\u015f\u0131ya eri\u015fimi olan gruplarda daha az demans tan\u0131s\u0131 kondu\u011funu ifade etti. Bilgi\u00e7, bu \u00e7al\u0131\u015fmalara ek olarak geni\u015f sa\u011fl\u0131k sistemi verilerinin de a\u015f\u0131 olanlarda demans riskini daha d\u00fc\u015f\u00fck buldu\u011funa dikkat \u00e7ekti.<\/p>\n

Bu bulgular\u0131n toplum sa\u011fl\u0131\u011f\u0131 a\u00e7\u0131s\u0131ndan b\u00fcy\u00fck \u00f6nem ta\u015f\u0131d\u0131\u011f\u0131n\u0131 vurgulayan Bilgi\u00e7, demans\u0131n hasta ve bak\u0131m verenleri ile aileleri \u00fczerinde a\u011f\u0131r bir y\u00fck olu\u015fturdu\u011funu; sa\u011fl\u0131k hizmetleri ve bak\u0131m maliyetlerinin toplum kaynaklar\u0131n\u0131 zorlad\u0131\u011f\u0131n\u0131 belirtti. Zona a\u015f\u0131lar\u0131n\u0131n demans riskini azaltt\u0131\u011f\u0131na dair kan\u0131tlar\u0131n, ya\u015fl\u0131 eri\u015fkinlerin a\u015f\u0131ya daha kolay ula\u015fmas\u0131n\u0131 sa\u011flamak i\u00e7in a\u015f\u0131 eri\u015fimini ve kapsama alan\u0131n\u0131 geni\u015fletmenin nispeten d\u00fc\u015f\u00fck maliyetli, pratik ve etkili bir se\u00e7enek oldu\u011funu g\u00f6sterdi\u011fini ifade etti.<\/p>\n

T\u00fcrkiye Alzheimer Derne\u011fi, ya\u015fl\u0131 eri\u015fkinlerde zona a\u015f\u0131s\u0131na eri\u015fimi h\u0131zland\u0131rmak ve kapsam\u0131 geni\u015fletmek \u00fczere ulusal d\u00fczeyde koordineli bir a\u015f\u0131lama program\u0131 ba\u015flat\u0131lmas\u0131 \u00e7a\u011fr\u0131s\u0131nda bulundu. Dernek, program\u0131n \u00f6ncelikle 65 ya\u015f ve \u00fczeri ki\u015fileri hedeflemesi, a\u015f\u0131 temini, \u00fccretsiz uygulama ve uzun d\u00f6nem bili\u015fsel izlemi i\u00e7erecek \u015fekilde tasarlanmas\u0131 gerekti\u011fini belirtti.<\/p>\n

Alzheimer\u2019da ortaya \u00e7\u0131kan h\u0131r\u00e7\u0131nl\u0131klarla m\u00fccadele m\u00fcmk\u00fcn<\/strong><\/p>\n

T\u00fcrkiye Alzheimer Derne\u011fi Y\u00f6netim Kurulu \u00dcyesi ve hasta yak\u0131n\u0131 Hatice Serta\u00e7 S\u00fcsl\u00fc<\/strong>, Alzheimer hastalar\u0131nda g\u00f6r\u00fclen h\u0131r\u00e7\u0131nl\u0131k ve huzursuzlu\u011fun hem hasta hem de bak\u0131m verenler i\u00e7in y\u0131prat\u0131c\u0131 bir sorun oldu\u011funu; g\u00fcnl\u00fck ya\u015fam\u0131, uyku d\u00fczenini ve sosyal ili\u015fkileri bozdu\u011funu, bak\u0131m y\u00fck\u00fcn\u00fc ve sa\u011fl\u0131k harcamalar\u0131n\u0131 art\u0131rd\u0131\u011f\u0131n\u0131 ve hastal\u0131\u011f\u0131n seyrini olumsuz etkiledi\u011fini belirtti.<\/p>\n

Bu durumun \u00e7aresiz olmad\u0131\u011f\u0131n\u0131 ve tedavi edilebildi\u011fini vurgulayan S\u00fcsl\u00fc, ailelerin \u201cajitasyon\u201d ad\u0131 verilen bu belirtileri tan\u0131mas\u0131n\u0131n, de\u011fi\u015fiklikleri g\u00f6zlemleyip not almas\u0131n\u0131n ve bu konuda hekimle konu\u015fmas\u0131n\u0131n erken m\u00fcdahale ve do\u011fru y\u00f6nlendirme i\u00e7in hayati \u00f6nem ta\u015f\u0131d\u0131\u011f\u0131n\u0131 s\u00f6yledi.<\/p>\n

Bu davran\u0131\u015f sorunlar\u0131na y\u00f6nelik olarak \u00f6ncelikle ila\u00e7 d\u0131\u015f\u0131 yakla\u015f\u0131mlar\u0131n uygulanmas\u0131 gerekti\u011fini belirten S\u00fcsl\u00fc; hasta \u00f6zelinde uygun bak\u0131m d\u00fczenlemeleri, ya\u015fam ortam\u0131n\u0131n sadele\u015ftirilip uyar\u0131c\u0131lar\u0131n azalt\u0131lmas\u0131, d\u00fczenli ve hafif fiziksel aktivite, m\u00fczik veya sanat temelli destekler ile bak\u0131m verenlerin e\u011fitiminin h\u0131r\u00e7\u0131nl\u0131k ataklar\u0131n\u0131n hem s\u0131kl\u0131\u011f\u0131n\u0131 hem de \u015fiddetini azaltt\u0131\u011f\u0131n\u0131 ifade etti. \u0130la\u00e7 d\u0131\u015f\u0131 y\u00f6ntemlere yan\u0131t vermeyen hastalarda hekim de\u011ferlendirmesiyle ila\u00e7 tedavilerinin g\u00fcndeme geldi\u011fini aktaran S\u00fcsl\u00fc, son y\u0131llarda Alzheimer hastal\u0131\u011f\u0131nda g\u00f6r\u00fclen bu h\u0131r\u00e7\u0131nl\u0131klara \u00f6zel olarak iki onayl\u0131 ila\u00e7 geli\u015ftirildi\u011fini ve bunlardan birinin T\u00fcrkiye\u2019de mevcut oldu\u011funu belirtti. S\u00fcsl\u00fc ayr\u0131ca geli\u015ftirilmekte olan yeni tedavi adaylar\u0131n\u0131n \u00f6n\u00fcm\u00fczdeki d\u00f6nemde davran\u0131\u015f sorunlar\u0131n\u0131n tedavisinde ek se\u00e7enekler sunarak hastalara ve bak\u0131m verenlere \u00f6nemli \u00f6l\u00e7\u00fcde rahatlama sa\u011flayabilece\u011fine dikkat \u00e7ekti.<\/p>\n

\u201cBir Sebebi Varm\u0131\u015f, Art\u0131k Biliyorum\u201d kampanyas\u0131 ile davran\u0131\u015fsal belirtilere dikkat \u00e7ekiliyor<\/strong><\/p>\n

Toplant\u0131da, T\u00fcrkiye Alzheimer Derne\u011fi ve Abdi \u0130brahim Otsuka i\u015f birli\u011fiyle y\u00fcr\u00fct\u00fclen \u201cBir Sebebi Varm\u0131\u015f, Art\u0131k Biliyorum\u201d<\/strong> kampanyas\u0131n\u0131n oda\u011f\u0131nda yer alan davran\u0131\u015fsal belirtilere de dikkat \u00e7ekildi. Kampanya ile Alzheimer hastal\u0131\u011f\u0131nda g\u00f6r\u00fclebilen huysuzluk, huzursuzluk ve ajitasyon gibi davran\u0131\u015flar\u0131n g\u00f6z ard\u0131 edilmemesi; hasta yak\u0131nlar\u0131 ve bak\u0131m verenlerin bu davran\u0131\u015flar\u0131n hastal\u0131kla ili\u015fkili nedenleri olabilece\u011fi konusunda fark\u0131ndal\u0131k kazanmas\u0131 ama\u00e7lan\u0131yor.<\/p>\n

Abdi \u0130brahim Otsuka Genel M\u00fcd\u00fcr\u00fc Zeynep Alptekin Basa<\/strong>, Alzheimer\u2019\u0131n yaln\u0131zca hastay\u0131 de\u011fil, ona bak\u0131m veren yak\u0131nlar\u0131n\u0131 ve dolay\u0131s\u0131yla t\u00fcm toplumu etkileyen \u00e7ok boyutlu bir sa\u011fl\u0131k sorunu oldu\u011funa dikkat \u00e7ekerek \u015funlar\u0131 s\u00f6yledi: \u201cAlzheimer denildi\u011finde \u00e7o\u011fumuzun akl\u0131na ilk olarak unutkanl\u0131k ve haf\u0131za kayb\u0131 geliyor. Oysa hastal\u0131\u011f\u0131n seyrinde huysuzluk, huzursuzluk ve ajitasyon gibi davran\u0131\u015fsal belirtiler de g\u00f6r\u00fclebilir. Bu belirtiler bazen ki\u015finin karakterinin de\u011fi\u015fti\u011fi ya da bilin\u00e7li olarak b\u00f6yle davrand\u0131\u011f\u0131 \u015feklinde yorumlanabiliyor. \u2018Bir Sebebi Varm\u0131\u015f, Art\u0131k Biliyorum\u2019 kampanyas\u0131yla tam da bu bak\u0131\u015f a\u00e7\u0131s\u0131nda bir de\u011fi\u015fim yaratmay\u0131 ama\u00e7l\u0131yoruz. \u0130lk bak\u0131\u015fta anlam verilemeyen baz\u0131 davran\u0131\u015flar\u0131n ard\u0131nda hastal\u0131kla ili\u015fkili nedenler olabilece\u011finin bilinmesini; hasta yak\u0131nlar\u0131n\u0131n ve bak\u0131m verenlerin bu belirtileri daha iyi g\u00f6zlemleyerek hekimleriyle payla\u015fmalar\u0131n\u0131 \u00f6nemsiyoruz. \u00c7\u00fcnk\u00fc bir davran\u0131\u015f\u0131n nedenini anlaman\u0131n, hastaya yakla\u015f\u0131m\u0131m\u0131z\u0131 ve bak\u0131m s\u00fcrecini de de\u011fi\u015ftirebilece\u011fine inan\u0131yoruz.\u201d<\/p>\n

Kronik hastal\u0131klarla m\u00fccadele eden bireylerin ve onlara destek olan bak\u0131m verenlerin daha kaliteli bir ya\u015fam\u0131 hak ettikleri inanc\u0131yla \u00e7al\u0131\u015fmalar\u0131n\u0131 s\u00fcrd\u00fcrd\u00fcklerini belirten Basa, en \u00f6nemli odak alanlar\u0131ndan birinin de Alzheimer\u2019\u0131n da i\u00e7inde bulundu\u011fu n\u00f6ropsikiyatrik hastal\u0131klar oldu\u011funu ifade etti. Hasta ve bak\u0131m verenlerin ya\u015fam kalitesinin birlikte ele al\u0131nmas\u0131 gerekti\u011fine dikkat \u00e7eken Basa, bu alanda yenilik\u00e7i sa\u011fl\u0131k \u00e7\u00f6z\u00fcmlerinin yan\u0131 s\u0131ra sosyal etki yaratacak g\u00fc\u00e7l\u00fc i\u015f birlikleriyle fark\u0131ndal\u0131\u011f\u0131n art\u0131r\u0131lmas\u0131na katk\u0131 sa\u011flamay\u0131 \u00f6nemsediklerini vurgulad\u0131.<\/p>\n

\u00a0<\/p>\n

Kaynak: (BYZHA) Beyaz Haber Ajans\u0131<\/p>\n","protected":false},"excerpt":{"rendered":"

21 Eyl\u00fcl D\u00fcnya Alzheimer G\u00fcn\u00fc vesilesiyle d\u00fczenlenen bas\u0131n toplant\u0131s\u0131nda; Alzheimer hastal\u0131\u011f\u0131nda tan\u0131 ve tedavi alan\u0131ndaki g\u00fcncel bilimsel geli\u015fmeler, yeni tedavilere eri\u015fim, hastal\u0131\u011f\u0131n davran\u0131\u015fsal belirtileri ve bak\u0131m verenlerin ya\u015fad\u0131\u011f\u0131 zorluklar ele al\u0131nd\u0131.<\/p>\n","protected":false},"author":1,"featured_media":34655,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[23],"tags":[],"class_list":["post-34654","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/34654","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/comments?post=34654"}],"version-history":[{"count":1,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/34654\/revisions"}],"predecessor-version":[{"id":34656,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/34654\/revisions\/34656"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/media\/34655"}],"wp:attachment":[{"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/media?parent=34654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/categories?post=34654"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/tags?post=34654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}